Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John P Middleton

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
Kidney International|November 3, 2024
Effects of dialysate potassium concentration of 3.0 mmol/l with sodium zirconium cyclosilicate on dialysis-free days versus dialysate potassium concentration of 2.0 mmol/l alone on rates of cardiac arrhythmias in hemodialysis patients with hyperkalemiaDavid M Charytan, Wolfgang C Winkelmayer, Christopher B Granger, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 19, 2014
Primary prevention implantable cardioverter defibrillators in end-stage kidney disease patients on dialysis: a matched cohort studyPatrick H Pun, Anne S Hellkamp, Gillian D Sanders, et al.
Clinical Journal of the American Society of Nephrology : CJASN|January 2, 2009
Outcomes of Staphylococcus aureus infection in hemodialysis-dependent patientsYanhong Li, Joëlle Y Friedman, Betsy F O'Neal, et al.
Journal of the American Society of Nephrology : JASN|May 16, 2019
Effects of Nicotinamide and Lanthanum Carbonate on Serum Phosphate and Fibroblast Growth Factor-23 in CKD: The COMBINE TrialJoachim H Ix, Tamara Isakova, Brett Larive, et al.
Kidney International Reports|March 14, 2024
Targeting Gut Microbiome With Prebiotic in Patients With CKD: The TarGut-CKD StudyMichael B Sohn, Bei Gao, Cynthia Kendrick, et al.
American Journal of Nephrology|November 13, 2009
CYP3A4 and CYP3A5 polymorphisms and blood pressure response to amlodipine among African-American men and women with early hypertensive renal diseaseVibha Bhatnagar, Erin P Garcia, Daniel T O'Connor, et al.
American Journal of Hypertension|January 3, 2009
G-protein-coupled receptor kinase 4 polymorphisms and blood pressure response to metoprolol among African Americans: sex-specificity and interactionsVibha Bhatnagar, Daniel T O'Connor, Victoria H Brophy, et al.
Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation|November 23, 2025
Prebiotic Administration to CKD Patients Modifies Their Microbiome and MetabolismDominic S Raj, Bei Gao, Michael B Sohn, et al.
JAMA|November 21, 2002
Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trialJackson T Wright, George Bakris, Tom Greene, et al.
Clinical Trials (London, England)|December 2, 2005
Design of the Dialysis Access Consortium (DAC) Clopidogrel Prevention of Early AV Fistula Thrombosis TrialLaura M Dember, James S Kaufman, Gerald J Beck, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Kidney International|November 3, 2024
Effects of dialysate potassium concentration of 3.0 mmol/l with sodium zirconium cyclosilicate on dialysis-free days versus dialysate potassium concentration of 2.0 mmol/l alone on rates of cardiac arrhythmias in hemodialysis patients with hyperkalemiaDavid M Charytan, Wolfgang C Winkelmayer, Christopher B Granger, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 19, 2014
Primary prevention implantable cardioverter defibrillators in end-stage kidney disease patients on dialysis: a matched cohort studyPatrick H Pun, Anne S Hellkamp, Gillian D Sanders, et al.
Clinical Journal of the American Society of Nephrology : CJASN|January 2, 2009
Outcomes of Staphylococcus aureus infection in hemodialysis-dependent patientsYanhong Li, Joëlle Y Friedman, Betsy F O'Neal, et al.
Journal of the American Society of Nephrology : JASN|May 16, 2019
Effects of Nicotinamide and Lanthanum Carbonate on Serum Phosphate and Fibroblast Growth Factor-23 in CKD: The COMBINE TrialJoachim H Ix, Tamara Isakova, Brett Larive, et al.
Kidney International Reports|March 14, 2024
Targeting Gut Microbiome With Prebiotic in Patients With CKD: The TarGut-CKD StudyMichael B Sohn, Bei Gao, Cynthia Kendrick, et al.
American Journal of Nephrology|November 13, 2009
CYP3A4 and CYP3A5 polymorphisms and blood pressure response to amlodipine among African-American men and women with early hypertensive renal diseaseVibha Bhatnagar, Erin P Garcia, Daniel T O'Connor, et al.
American Journal of Hypertension|January 3, 2009
G-protein-coupled receptor kinase 4 polymorphisms and blood pressure response to metoprolol among African Americans: sex-specificity and interactionsVibha Bhatnagar, Daniel T O'Connor, Victoria H Brophy, et al.
Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation|November 23, 2025
Prebiotic Administration to CKD Patients Modifies Their Microbiome and MetabolismDominic S Raj, Bei Gao, Michael B Sohn, et al.
JAMA|November 21, 2002
Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trialJackson T Wright, George Bakris, Tom Greene, et al.
Clinical Trials (London, England)|December 2, 2005
Design of the Dialysis Access Consortium (DAC) Clopidogrel Prevention of Early AV Fistula Thrombosis TrialLaura M Dember, James S Kaufman, Gerald J Beck, et al.
Pageof 4